Novartis Aktie
113,25
EUR
-0,35
EUR
-0,31
%
104,68
CHF
-0,18
CHF
-0,17
%
Werbung
Novartis Aktie Analyse
18.07.23 | Novartis Buy | Jefferies & Company Inc. | |
10.07.23 | Novartis Buy | Deutsche Bank AG | |
05.07.23 | Novartis Buy | Jefferies & Company Inc. | |
15.06.23 | Novartis Underweight | Barclays Capital | |
15.06.23 | Novartis Neutral | UBS AG | |
13.06.23 | Novartis Buy | Deutsche Bank AG | |
09.06.23 | Novartis Buy | Jefferies & Company Inc. | |
06.06.23 | Novartis Buy | Deutsche Bank AG | |
Werbung
|
|||
05.06.23 | Novartis Neutral | UBS AG | |
05.06.23 | Novartis Buy | Deutsche Bank AG | |
05.06.23 | Novartis Underweight | Barclays Capital | |
02.06.23 | Novartis Buy | Jefferies & Company Inc. | |
19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
18.05.23 | Novartis Neutral | UBS AG | |
02.05.23 | Novartis Buy | Jefferies & Company Inc. | |
26.04.23 | Novartis Underperform | Credit Suisse Group | |
26.04.23 | Novartis Underweight | Barclays Capital | |
26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
26.04.23 | Novartis Buy | Deutsche Bank AG | |
25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
11.04.23 | Novartis Underweight | Barclays Capital | |
28.03.23 | Novartis Neutral | UBS AG | |
28.03.23 | Novartis Hold | Deutsche Bank AG | |
27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
14.03.23 | Novartis Sell | Deutsche Bank AG | |
17.02.23 | Novartis Sell | Deutsche Bank AG | |
13.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
07.02.23 | Novartis Sell | Deutsche Bank AG | |
06.02.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.02.23 | Novartis Neutral | JP Morgan Chase & Co. | |
02.02.23 | Novartis Underperform | Credit Suisse Group | |
02.02.23 | Novartis Sell | Deutsche Bank AG | |
01.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.23 | Novartis Buy | Jefferies & Company Inc. | |
01.02.23 | Novartis Neutral | UBS AG | |
25.01.23 | Novartis Underweight | Barclays Capital | |
24.01.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
09.01.23 | Novartis Neutral | UBS AG | |
06.01.23 | Novartis Underperform | Credit Suisse Group | |
06.01.23 | Novartis Underweight | Morgan Stanley | |
05.01.23 | Novartis Buy | Jefferies & Company Inc. | |
03.01.23 | Novartis Neutral | JP Morgan Chase & Co. | |
23.12.22 | Novartis Underweight | Barclays Capital | |
14.12.22 | Novartis Neutral | UBS AG | |
12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
09.12.22 | Novartis Sell | Deutsche Bank AG | |
08.12.22 | Novartis Market-Perform | Bernstein Research | |
08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung